Navigation Links
They Call It PMS Because Mad Cow Disease Was Already Taken

Premenstrual syndrome is an endocrine disorder characterized by nervous irritability, abnormal sensation in breasts, abdominal pain, thirst, headache and pelvic congestion.

For the first time, low dose oral contraceptive with a unique progestin and dosing regimen has been found effective in treating symptoms of premenstrual dysphoric disorder// (PMDD), the most severe form of premenstrual syndrome.

PMDD is characterized by cyclical mood, behavioral and physical symptoms that can be debilitating in some women. The cause of PMDD is unknown, although changes in steroid hormone levels have been held responsible for symptom production. On the same basis, hormones can be given to suppress ovarian activity thereby preventing the symptoms in these women.

A multi-center, double-blind, randomized clinical trial was conducted involving 450 women with symptoms of PMDD. The participants were given either the oral contraceptive or a placebo. Women who were given the oral contraceptive had significantly greater improvement (48.4 percent compared to 36.1 percent of women on placebo) in productivity, enjoyment of hobbies, social activities, and interpersonal relationships, and experienced greater symptom reduction. Forty-four women from both groups withdrew from the study due to adverse effects such as nausea and intermenstrual bleeding.

The low dose oral contraceptive contains drospirenone, a new progestin, and ethinyl estradiol. It was administered for 24 days followed by four days of inactive pills. The new regimen was designed for greater ovarian suppression and a more stable hormonal environment. The women were evaluated over the course of two menstrual cycles.

The analysis of the results has proved that the oral contraceptive method is effective in reducing symptoms associated with the PMS. For women who are seeking contraception in addition to control of PMDD, this would be more efficient because they could take just on e treatment.


'"/>




Related medicine news :

1. More Britons Take To Alcohol Because Of Stress
2. Do Women Die In Childbirth Because It Is More Preferable?
3. No Kidding, Children Obese Because of Overeating
4. Your Kids may Not Be Fat Because of too Much TV or Video Games
5. TB Cases, Deaths Decline in Yemen Because of Awareness Programs
6. Number of TB Cases in Malta Increasing in Part Because of Immigration
7. Junior Doctors Facing More Misery Because of Contract Deadlock: BMA
8. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
9. Vitamins-The answer to Heart Disease?
10. Link between Constipation and Parkinsons Disease
11. Levels Of Blood Proteins May Help Heart Disease Care
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the ... medical article to the newly revamped Cosmetic Town journal section, featuring ... transplant procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... named one of Michigan’s 2017 Best and Brightest in Wellness® by Best and ... Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... Mass. , Oct. 4, 2017 ... of single-use, self-contained, illuminating medical devices, today announced ... National Health Surveillance Agency (or Agência Nacional de ... The first single-use, cordless surgical retractor with integrated ... provides optimal access, illumination and exposure of a ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
(Date:10/2/2017)... Oct. 2, 2017 Halo Labs announces the European launch ... called the HORIZON at MIBio 2017 in Cambridge, U.K ... visible particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity ... novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
Breaking Medicine Technology: